Phosphodiesterase 3 Inhibitors
"Phosphodiesterase 3 Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that specifically inhibit PHOSPHODIESTERASE 3.
| Descriptor ID |
D058987
|
| MeSH Number(s) |
D27.505.519.389.735.249
|
| Concept/Terms |
Phosphodiesterase 3 Inhibitors- Phosphodiesterase 3 Inhibitors
- Inhibitors, Phosphodiesterase 3
- Phosphodiesterase Type 3 Inhibitors
- PDE-3 Inhibitors
- Inhibitors, PDE-3
- PDE 3 Inhibitors
- PDE3 Inhibitors
- Inhibitors, PDE3
|
Below are MeSH descriptors whose meaning is more general than "Phosphodiesterase 3 Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Phosphodiesterase 3 Inhibitors".
This graph shows the total number of publications written about "Phosphodiesterase 3 Inhibitors" by people in this website by year, and whether "Phosphodiesterase 3 Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphodiesterase 3 Inhibitors" by people in Profiles.
-
Gurabi Z, Koncz I, Patocskai B, Nesterenko VV, Antzelevitch C. Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):134-42.
-
Sz?l T, Koncz I, Antzelevitch C. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome. Heart Rhythm. 2013 Nov; 10(11):1720-7.
-
Garimella PS, Hart PD, O'Hare A, DeLoach S, Herzog CA, Hirsch AT. Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care. Am J Kidney Dis. 2012 Oct; 60(4):641-54.